Marinus Pharmaceuticals
Stock Forecast, Prediction & Price Target
Marinus Pharmaceuticals Financial Estimates
Marinus Pharmaceuticals Revenue Estimates
Marinus Pharmaceuticals EBITDA Estimates
Marinus Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $15.34M N/A | $25.47M 66.03% | $30.98M 21.63% | Avg: $58.16M Low: $42.34M High: $84.97M avg. 87.70% | Avg: $112.97M Low: $85.51M High: $163.14M avg. 94.22% | Avg: $195.08M Low: $147.66M High: $281.71M avg. 72.67% | Avg: $284.09M Low: $215.03M High: $410.25M avg. 45.62% |
Net Income
% change YoY
| $-101.66M N/A | $-19.81M 80.50% | $-141.40M -613.59% | Avg: $-78.66M Low: $-110.71M High: $-31.71M avg. 44.37% | Avg: $-28.55M Low: $-33.32M High: $-5.37M avg. 63.69% | Avg: $19.80M Low: $13.54M High: $31.23M avg. 169.34% | Avg: $61.31M Low: $41.93M High: $96.70M avg. 209.65% |
EBITDA
% change YoY
| $-96.19M N/A | $-5.75M 94.01% | $-125.49M -2080.66% | Avg: $-25.89M Low: $-37.82M High: $-18.85M avg. 79.36% | Avg: $-50.29M Low: $-72.62M High: $-38.06M avg. -94.22% | Avg: $-86.84M Low: $-125.41M High: $-65.73M avg. -72.67% | Avg: $-126.47M Low: $-182.63M High: $-95.72M avg. -45.62% |
EPS
% change YoY
| -$2.77 N/A | -$0.51 81.58% | -$2.63 -415.68% | Avg: -$1.04 Low: -$2.06 High: -$0.59 avg. 60.53% | Avg: -$0.27 Low: -$0.62 High: -$0.1 avg. 73.82% | Avg: $0.37 Low: $0.25 High: $0.58 avg. 235.61% | Avg: $1.14 Low: $0.78 High: $1.8 avg. 209.65% |
Operating Expenses
% change YoY
| $110.79M N/A | $137.92M 24.48% | $160.54M 16.39% | Avg: $214.41M Low: $156.09M High: $313.22M avg. 33.55% | Avg: $416.45M Low: $315.20M High: $601.37M avg. 94.22% | Avg: $719.12M Low: $544.29M High: $1.03B avg. 72.67% | Avg: $1.04B Low: $792.63M High: $1.51B avg. 45.62% |
FAQ
What is Marinus Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 121.76% in 2025-2028.
We have gathered data from 9 analysts. Their low estimate is -110.71M, average is -78.66M and high is -31.71M.
What is Marinus Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 75.05% in 2025-2028.
We have gathered data from 9 analysts. Their low revenue estimate is $42.34M, average is $58.16M and high is $84.97M.
What is Marinus Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 144.90% in 2025-2028.
We have gathered data from 9 analysts. Their low earnings per share estimate is -$2.06, average is -$1.04 and high is $-0.59.
What is the best performing analyst?
In the last twelve months analysts have been covering Marinus Pharmaceuticals stock. The most successful analyst is Brian Skorney.